FREE Account Opening + No Clearing Fees
Loading...

Krsnaa Diagnostics IPO vs Windlas Biotech IPO

Comparision between Krsnaa Diagnostics IPO and Windlas Biotech IPO.

IPO Details

Krsnaa Diagnostics IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Krsnaa Diagnostics IPO is up to ₹1,213.33 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Krsnaa Diagnostics IPO is ₹954.00 per share and of Windlas Biotech IPO is ₹460.00 per share.

  Krsnaa Diagnostics IPO Windlas Biotech IPO
Face Value ₹5 per share ₹5 per share
Issue Price (Lower) ₹933.00 per share ₹448.00 per share
Issue Price (Upper) ₹954.00 per share ₹460.00 per share
Issue Price (Final) ₹954.00 per share ₹460.00 per share
Discount (Retail)
Discount (Employee) ₹93.00 per share
Market Lot Size 15 shares 30 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹400.00 Cr up to ₹165.00 Cr
OFS Issue Size 85,25,520 shares 51,42,067 shares
OFS Issue Size (Amount) up to ₹813.33 Cr up to ₹236.54 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹1,213.33 Cr up to ₹401.54 Cr

IPO Timetable

Krsnaa Diagnostics IPO opens on Aug 04, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Krsnaa Diagnostics IPO and Windlas Biotech IPO is Aug 06, 2021, and Aug 06, 2021, respectively.

  Krsnaa Diagnostics IPO Windlas Biotech IPO
Anchor Bid Date
Issue Open Aug 04, 2021 Aug 04, 2021
Issue Close Aug 06, 2021 Aug 06, 2021
Basis Of Allotment (Tentative) Aug 11, 2021 Aug 11, 2021
Initiation of Refunds (Tentative) Aug 12, 2021 Aug 12, 2021
Credit of Share (Tentative) Aug 13, 2021 Aug 13, 2021
Listing date (Tentative) Aug 16, 2021 Aug 16, 2021
Anchor Lockin End date 1 Sep 10, 2021 Sep 10, 2021
Anchor Lockin End date 2 Nov 09, 2021 Nov 09, 2021

Financials

Krsnaa Diagnostics IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .

  Krsnaa Diagnostics IPO Windlas Biotech IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 6,045.30 6,299.82 5,289.85
Total Revenue 6,614.76 2,713.79 2,143.15
Profit After Tax 1,849.29 (1,119.51) (580.57)
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2,961.23 3,384.88 2,981.80
Total Revenue 4,306.95 3,313.39 3,115.25
Profit After Tax 155.70 162.13 638.22
Promoter Shareholding (Pre-Issue) 31.62% 78%
Promoter Shareholding (Post-Issue) 27.38% 65.16%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Krsnaa Diagnostics IPO retail investors (RII) are offered 12,50,874 shares while in Windlas Biotech IPO retail investors are offered 12,50,874 shares. Qualified institutional buyers (QIB) are offered 37,52,625 shares in Krsnaa Diagnostics IPO and 17,23,700 shares in Windlas Biotech IPO.

  Krsnaa Diagnostics IPO Windlas Biotech IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 37,52,625 shares 17,23,700 shares
NII 18,76,312 shares 13,23,766 shares
RII 12,50,874 shares 30,88,786 shares
Employee 2,32,288 shares 0 shares
Others
Total 71,12,099 shares 61,36,252 shares

Bids Received (Subscription)

Krsnaa Diagnostics IPO subscribed 64.38x in total, whereas Windlas Biotech IPO subscribed 22.44x.

  Krsnaa Diagnostics IPO Windlas Biotech IPO
QIB (times) 49.83x 24.40x
NII (times) 116.30x 15.73x
Big NII (times)
Small NII (times)
RII (times) 41.95x 24.22x
Employee (times) 0.98x
Other (times)
Total (times) 64.38x 22.44x

Comments

Add a public comment...